Effects of selenium supplementation on concurrent chemoradiotherapy in patients with cervical cancer: A randomized, double-blind, placebo-parallel controlled phase II clinical trial

OBJECTIVE: Selenium (Se) is an essential trace element and may affect cervical cancer occurrence and progression. The association between selenium supplementation and acute toxic reactions and clinical outcomes in patients with locally advanced cervical cancer treated with concurrent chemoradiothera...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Mei, Pei, Bo, Hu, Qiancheng, Li, Xiaoying, Fang, Xiping, Huang, Xue, Yang, Zunjing, Chen, Jiaquan, He, Du, Sun, Guogen, Lv, Peng, Wang, Li, Zhang, Zixiong, Lai, Lin, Huang, Chuying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Nutrition
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932900/
https://www.ncbi.nlm.nih.gov/pubmed/36819673
http://dx.doi.org/10.3389/fnut.2023.1094081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932900/
https://www.ncbi.nlm.nih.gov/pubmed/36819673
http://dx.doi.org/10.3389/fnut.2023.1094081

Ejemplares similares